"Selayang Hospital is a fully government hospital with 960 inpatient beds and 20 clinical disciplines located in Selayang in the Gombak District, Selangor, Malaysia. This hospital provides secondary and selected national tertiary care services. Located in Batu Caves, Malaysia."

During the past decade, Hospital Selayang conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Selayang" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Bayer" with 1 trials sponsored, "Human Genome Sciences Inc." with 1 trials sponsored, "Ministry of Health, Malaysia" with 1 trials sponsored and "Penang Hospital, Malaysia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Selayang" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "GeneNews Sdn Bhd" with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator, "Ministry of Health, Malaysia" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Selayang" are "Chronic Kidney Disease" (2 trials), "Generalized Pustular Psoriasis" (2 trials), "Scleroderma, Systemic" (2 trials), "Carcinoma,Hepatocellular" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Hospital Selayang" in a lesser frequency.

Most popular intervention types in "Hospital Selayang" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "BI 685509" (3 trials), "Spesolimab" (2 trials), "BI 456906" (1 trials) and "Dextrose 5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Selayang" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Selayang". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Selayang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Selayang, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".